Laverdia-CA1 (Verdinexor) is a cancer drug with conditional FDA approval for use in treating lymphoma in dogs. The active ingredient, verdinexor, prevents tumor suppressing proteins from leaving the nucleus of cells. As a result, the eventual death of cancer cells often occurs. This is the first tablet for the treatment of lymphoma in dogs to achieve conditional approval from the FDA. Read all instructions regarding handling and storage carefully.Follow exact dosing instructions provided by your veterinarian. Consider AutoShip for this and the other medications and parasite preventatives you need. With Autoship's automatic delivery, you'll have one less thing to worry about, so you can spend more time focusing on helping your pet get well.
Key Benefits:
Formulated For: Dogs
Health Consideration: Cancer
How is Medication Given? Use as directed by your Veterinarian.
What Results Can I Expect? Laverdia-CA1 contains verdinexor, which disrupts - and eventually kills - cancer cells by stopping tumor suppressing proteins.
What Form Does Medication Come In? Laverdia-CA1 is sold in three strength options: 2.5 mg, 10 mg, and 50 mg tablets. All dosage strengths are available in 50 tablet bottles. The 50 mg strength is also available in a 16 tablet bottle.
Manufacturer: Dechra
Common Brand Name: Laverdia-CA1
Dose and Administration: Use as directed by your Veterinarian.
Possible Side Effects: Anorexia, weigh loss, elevated liver enzymes, vomiting, and diarrhea are among the most common side effects of dogs taking Laverdia-CA1.
Storage Recommendations: Store the bottles at controlled room temperature 20 to 25 degrees C (68-77 degrees F).
In Case of Overdose: Contact your nearest emergency animal hospital.
Is Prescription from a Vet Required? Yes
